Age at initiation of amphetamine use and age at onset of psychosis: The Australian survey of high impact psychosis

Schizophrenia Research

Volumn 152, Issue 1, 2014, Pages 300-302

  Power, Brian D ^a,b,c   Stefanis, Nikos C ^a,b   Dragovic, Milan ^a,b   Jablensky, Assen ^a   Castle, David ^d   Morgan, Vera ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Clinical Applications Unit   (Australia)

^c South Metropolitan Area Health Service   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amphetamine; Cannabis; Causality; Psychosis; Schizophrenia

Indexed keywords

AMPHETAMINE; CANNABIS;

ADULT; ARTICLE; EXPOSURE; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MIDDLE AGED; ONSET AGE; PRIORITY JOURNAL; PSYCHOSIS; SEMI STRUCTURED INTERVIEW; SUBSTANCE USE; YOUNG ADULT; ASSOCIATION; CALCULATION; CANNABIS USE; CONTROLLED STUDY; DRUG EXPOSURE; SCHIZOPHRENIA; STATISTICAL MODEL;

AGE AT INITIATION TO AMPHETAMINE; AGE AT ONSET OF ILLNESS; AIA; AMPHETAMINE; AOI; CANNABIS; CAUSALITY; DIAGNOSTIC INTERVIEW FOR PSYCHOSIS; DIP; DPEA; DURATION OF PREMORBID EXPOSURE TO AMPHETAMINE; PSYCHOSIS; SCHIZOPHRENIA; SHIP; SURVEY OF HIGH IMPACT PSYCHOSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AMPHETAMINE-RELATED DISORDERS; AUSTRALIA; CATCHMENT AREA (HEALTH); FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84891630212     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.11.003     Document Type: Article

References (15)

1. Barnes T.R., Mutsatsa S.H., Hutton S.B., Watt H.C., Joyce E.M. Comorbid substance use and age at onset of schizophrenia. Br. J. Psychiatry 2006, 188:237-242.
2. Boileau I., Dagher A., Leyton M., Gunn R.N., Baker G.B., Diksic M., Benkelfat C. Modeling sensitization to stimulants in humans. An [11C] Raclopride/Positron Emission Tomography Study in healthy men. Arch. Gen. Psychiatry 2006, 63:1386-1395.
3. Castle D., Jablensky A., McGrath J., Carr V., Morgan V., Waterreus A., Valuri G., Stain H., McGuffin P., Farmer A. The diagnostic interview for psychosis (DIP): development, reliability and applications. Psychol. Med. 2006, 36:69-80.
4. Chen C.K., Lin S.K., Sham P.C., Ball D., Loh E., Hsiao C.C., Chiang Y.L., Ree S.C., Lee C.H., Murray R.M. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol. Med. 2003, 33:1407-1414.
5. Dekker N., Meijer J., Koeter M., van den Brink W., van Beveren N. Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender. Psychol. Med. 2012, 42:1903-1911.
6. Farrell M., Boys A., Bebbington P., Brugha T., Coid J., Jenkins R., Lewis G., Meltzer H., Marsden J., Singleton N., Taylor C. Psychosis and drug dependence: results from a national survey of prisoners. Br. J. Psychiatry 2002, 181:393-398.
7. Gonzalez-Pinto A., Vega P., Ibanez B., Mosquera F., Barbeito S., Gutierrez M., Ruiz de Azua S., Ruiz I., Vieta E. Impact of cannabis and other drugs on age at onset of psychosis. J. Clin. Psychiatry 2008, 69:1210-1216.
8. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., Innis R.B. Single emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic patients. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9235-9240.
9. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch. Gen. Psychiatry 1991, 48:764-770.
10. Moore E., Mancuso S.G., Slade T., Galletly C., Castle D.J. The impact of alcohol and illicit drugs on people with psychosis: the second Australian national survey of psychosis. Aust. N. Z. J. Psychiatry 2012, 9:864-878.
11. Morgan V.A., Waterreus A., Jablensky A., Mackinnon A., McGrath J.J., Carr V., Bush R., Castle D., Cohen M., Harvey C., Galletly C., Stain H., Neill A.L., McGorry P., Hocking B., Shah S., Saw S. People living with psychotic illness in 2010: the second Australian national survey of psychosis. Aust. N. Z. J. Psychiatry 2012, 8:735-752.
12. Paparelli A., Di Forti M., Morrison P.D., Murray R.M. Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light. Front. Behav. Neurosci. 2011, 5:1-9.
13. Power B.D., Dragovic M., Jablensky A., Stefanis N.C. Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia?. Aust. N. Z. J. Psychiatry 2012, 47:51-58.
14. Stefanis N.C., Dragovic M., Power B.D., Jablensky A., Castle D., Morgan V.A. Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend. Schizophr. Bull. 2013, 39:251-254.
15. Stefanis N.C., Dragovic M., Power B.D., Jablensky A., Castle D., Morgan V.A. Drug use has differential effect on the age at onset in schizophrenia spectrum vs affective psychotic disorders: the Australian Survey of High Impact Psychosis. Schizophr. Bull. 2013, (submitted for publication).